Related Experiment Video
Updated: Sep 15, 2025

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
Delayed progressive apraxia of speech: A novel clinical entity distinct from primary progressive aphasia - A
Shun Akaike1, Shigehisa Ura2, Akihiko Ogata3
1Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
Background:
Primary progressive aphasia (PPA) is a neurodegenerative syndrome with language impairment as the initial, predominant symptom. However, speech-language impairments emerge later in the disease course in a subset of neurodegenerative disorders. We introduce the term delayed progressive aphasia (DPA) to describe this subset. Within DPA, we further define delayed progressive apraxia of speech (DPAOS), characterized by isolated apraxia of speech (AOS) without aphasia.
Methods:
We retrospectively reviewed patients with neurodegenerative diseases who developed speech-language impairment following an initial phase without speech or language symptoms. Six patients met the criteria for DPA and were compared with 11 patients exhibiting the nonfluent/agrammatic variant of PPA (naPPA), all of whom exhibited AOS. Disease duration since speech-language symptom onset was matched between groups. Neuropsychological performance was compared using Bayesian linear regression analysis.
Results:
All six patients who met the criteria for DPA exhibited isolated AOS without any aphasic symptoms. Accordingly, these cases were included in the DPAOS group. The Apraxia of Speech Rating Scale-3 scores were significantly lower in the DPAOS group than in the naPPA group, indicating milder AOS in the former. In the naPPA group, most patients exhibited more severe AOS, and several also showed agrammatism or anomia.
Conclusions:
DPAOS represents a clinically distinct presentation of progressive AOS that emerges after other neurological symptoms and remains relatively mild and isolated. Despite possible overlap in underlying pathology, DPAOS and naPPA differ in clinical course and speech-language impairment severity. This distinction may aid early detection of progressive speech disorders in certain neurodegenerative conditions.
More Related Videos
10:15Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
Published on: July 2, 2013
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Related Concept Videos
Parkinson's Disease: Overview
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Higher Mental Functions of the Brain: Language
Language formation and comprehension take place in the dominant hemisphere. The dominant hemisphere is responsible for understanding the meaning of spoken, written, or sign language, as well as the ability to communicate. For most people, the left hemisphere is the dominant one. The right hemisphere, then, gives tone and emotional context to the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Peripheral Artery Disease I: Introduction